240 related articles for article (PubMed ID: 24569991)
1. The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer-specific nanoclustering.
Guzmán C; Šolman M; Ligabue A; Blaževitš O; Andrade DM; Reymond L; Eggeling C; Abankwa D
J Biol Chem; 2014 Apr; 289(14):9519-33. PubMed ID: 24569991
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.
Blaževitš O; Mideksa YG; Šolman M; Ligabue A; Ariotti N; Nakhaeizadeh H; Fansa EK; Papageorgiou AC; Wittinghofer A; Ahmadian MR; Abankwa D
Sci Rep; 2016 Apr; 6():24165. PubMed ID: 27087647
[TBL] [Abstract][Full Text] [Related]
3. FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage.
Parkkola H; Siddiqui FA; Oetken-Lindholm C; Abankwa D
Methods Mol Biol; 2021; 2262():233-250. PubMed ID: 33977480
[TBL] [Abstract][Full Text] [Related]
4. H-Ras nanocluster stability regulates the magnitude of MAPK signal output.
Rotblat B; Belanis L; Liang H; Haklai R; Elad-Zefadia G; Hancock JF; Kloog Y; Plowman SJ
PLoS One; 2010 Aug; 5(8):e11991. PubMed ID: 20700538
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters.
Belanis L; Plowman SJ; Rotblat B; Hancock JF; Kloog Y
Mol Biol Cell; 2008 Apr; 19(4):1404-14. PubMed ID: 18234837
[TBL] [Abstract][Full Text] [Related]
6. ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.
Posada IM; Serulla M; Zhou Y; Oetken-Lindholm C; Abankwa D; Lectez B
PLoS One; 2016; 11(7):e0159677. PubMed ID: 27437940
[TBL] [Abstract][Full Text] [Related]
7. Ras membrane orientation and nanodomain localization generate isoform diversity.
Abankwa D; Gorfe AA; Inder K; Hancock JF
Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1130-5. PubMed ID: 20080631
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers.
Najumudeen AK; Posada IM; Lectez B; Zhou Y; Landor SK; Fallarero A; Vuorela P; Hancock J; Abankwa D
Biochemistry; 2015 Dec; 54(49):7212-21. PubMed ID: 26568031
[TBL] [Abstract][Full Text] [Related]
9. Targeting the α4-α5 interface of RAS results in multiple levels of inhibition.
Spencer-Smith R; Li L; Prasad S; Koide A; Koide S; O'Bryan JP
Small GTPases; 2019 Sep; 10(5):378-387. PubMed ID: 28692342
[TBL] [Abstract][Full Text] [Related]
10. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
[TBL] [Abstract][Full Text] [Related]
11. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.
Shalom-Feuerstein R; Plowman SJ; Rotblat B; Ariotti N; Tian T; Hancock JF; Kloog Y
Cancer Res; 2008 Aug; 68(16):6608-16. PubMed ID: 18701484
[TBL] [Abstract][Full Text] [Related]
12. Detection of Ras nanoclustering-dependent homo-FRET using fluorescence anisotropy measurements.
Babu Manoharan G; Guzmán C; Najumudeen AK; Abankwa D
Eur J Cell Biol; 2023 Jun; 102(2):151314. PubMed ID: 37058825
[TBL] [Abstract][Full Text] [Related]
13. Electrostatic interactions positively regulate K-Ras nanocluster formation and function.
Plowman SJ; Ariotti N; Goodall A; Parton RG; Hancock JF
Mol Cell Biol; 2008 Jul; 28(13):4377-85. PubMed ID: 18458061
[TBL] [Abstract][Full Text] [Related]
14. Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation.
Šolman M; Ligabue A; Blaževitš O; Jaiswal A; Zhou Y; Liang H; Lectez B; Kopra K; Guzmán C; Härmä H; Hancock JF; Aittokallio T; Abankwa D
Elife; 2015 Aug; 4():e08905. PubMed ID: 26274561
[TBL] [Abstract][Full Text] [Related]
15. Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.
Posada IMD; Lectez B; Sharma M; Oetken-Lindholm C; Yetukuri L; Zhou Y; Aittokallio T; Abankwa D
Oncotarget; 2017 Jul; 8(27):44550-44566. PubMed ID: 28562352
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs alter the spatiotemporal organization of Ras proteins on the plasma membrane.
Zhou Y; Cho KJ; Plowman SJ; Hancock JF
J Biol Chem; 2012 May; 287(20):16586-95. PubMed ID: 22433858
[TBL] [Abstract][Full Text] [Related]
17. Mathematical modeling of K-Ras nanocluster formation on the plasma membrane.
Tian T; Plowman SJ; Parton RG; Kloog Y; Hancock JF
Biophys J; 2010 Jul; 99(2):534-43. PubMed ID: 20643072
[TBL] [Abstract][Full Text] [Related]
18. Individual palmitoyl residues serve distinct roles in H-ras trafficking, microlocalization, and signaling.
Roy S; Plowman S; Rotblat B; Prior IA; Muncke C; Grainger S; Parton RG; Henis YI; Kloog Y; Hancock JF
Mol Cell Biol; 2005 Aug; 25(15):6722-33. PubMed ID: 16024806
[TBL] [Abstract][Full Text] [Related]
19. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction.
Tian T; Harding A; Inder K; Plowman S; Parton RG; Hancock JF
Nat Cell Biol; 2007 Aug; 9(8):905-14. PubMed ID: 17618274
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again.
Abankwa D; Gorfe AA
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
